A team of researchers from five Swedish universities have made a remarkable breakthrough in the treatment of cancer, with an equally innovative source of funding.
“We are first to show this new way of targeting cancer and this is likely going to be the major path for drug development in the future,” said Thomas Helleday, holder of the Söderberg Professorship at Karolinska Institutet, who heads the study.
Until now, most modern anti-cancer drugs have been tailored to target the genetic makeup of the cancer – a so-called personalized treatment. Sometimes this can have a long-lasting effect, but more often than not the cancers mutate to become resistant. What the team has managed to do is to target an enzyme that is required for all cancer cells for survival, but that normal cells do not need.
Helleday explained that the treatment – which comes in the form of a pill – can kill any cancer and does not have any severe side effects.
“Some say our finding sounds too good to be true, and I understand their gut feeling after seeing so many promising cancer treatments fail,” he said. “My research group has made paradigm shifts before and to those skeptics I say: just sit back and enjoy the revolution!”
What’s also revolutionary is the way the research is financed, through “open innovation” and “crowd sourcing”.
“I started a public foundation that owns all intellectual property and the idea is that we manufacture large amounts of the drug and provide it for free to the worldwide academic community, so they can design their own clinical trials and run them”, Helleday said.
“Also, as there is a public foundation behind the drug, it will not be used to enrich a few individuals, but be used for further work on new medicines.”
A lot of work remains to be done before it is time for clinical trials, which are still a year or two away, Helleday said.
Being based in Stockholm brings many advantages, including a number of highly trained drug developers looking for new challenges, he said.
“A major point is that Swedish Universities do not claim or take control on intellectual property, allowing us to donate it to a public foundation,” Helleday said.
“Another advantage is the collaborative nature of Swedes. We collaborated with five different universities to progress the project, which would have been difficult elsewhere.”
Their concept is presented in two articles in science journal Nature, with the aim of spreading the word to as many as possible in the research community.
“It has generated interest from academics across the world, to try the new concept on the cancer indication they have specialized in,” Helleday said.
The team has also sent out the compound to hundreds of scientists across the globe in an effort to increase the speed of innovation and to reach the goal of curing cancer more quickly. By freely sending out compounds, they have increased competition.
“Hundreds of scientists are advancing more quickly than one and we increase the chances of overall success,” Helleday said.
The Latest on: Cancer breakthrough
[google_news title=”” keyword=”Cancer breakthrough” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer breakthrough
- HUTCHMED Deserves An Upgrade After U.S. FDA Approval Of Cancer Drugon December 1, 2023 at 6:35 am
Takeda's FDA approval for FRUZAQLA in the US brings HUTCHMED a $35 million milestone payment, expanding their market. Click here to read my analysis.
- Rosenbaum helping champion breakthrough cancer therapies at Kurome Therapeuticson December 1, 2023 at 12:59 am
Rosenbaum always seemed destined for startup life. Following a 23-year stint as a scientist at Procter & Gamble, she finally stepped into the scene ...
- This Cork artist creates bespoke Christmas cards in aid of Breakthrough Cancer Researchon December 1, 2023 at 12:00 am
Breakthrough Cancer Research, together with renowned textile artist Fiona Turley, have launched a collection of Christmas cards with 100 per cent of the proceeds helping fund research for the ...
- AI tech being developed to detect early signs of lung canceron November 30, 2023 at 4:25 pm
Artificial intelligence technology is being harnessed in a new lung cancer detection system which is in development with BC Cancer.
- FDA warns breakthrough cancer treatment might cause canceron November 30, 2023 at 4:00 pm
In 2017, the U.S. Food and Drug Administration (FDA) approved a breakthrough treatment for blood cancer. But now, the agency cautions the treatment is not without risks and appears to have caused ...
- 80 years ago: The ‘Little Pearl Harbor’ attack and, later, a cancer breakthrough | GUEST COMMENTARYon November 30, 2023 at 10:36 am
The Allies tried to cover up the mustard gas disaster, but an Army physician deduced that chemical weapons were involved.
- Potential breakthrough in breast cancer: Five proteins identified as risk markerson November 28, 2023 at 2:49 am
Researchers used a Mendelian randomization approach to conduct a genetic association analysis of the levels of over 3,000 proteins to identify biomarkers for early breast cancer detection.
- AI breakthrough could save thousands of breast cancer patients from surgeryon November 27, 2023 at 7:00 am
Artificial intelligence can assess breast cancer better than doctors and could spare thousands of women unnecessary surgery, according to a new study. Breast cancer is the most common cancer in the UK ...
- A breakthrough in cancer vaccines may be coming, and Houston is a hub for clinical trialson November 24, 2023 at 4:00 am
The dream of widely available cancer vaccines is inching closer to reality, and much of the work toward a breakthrough is happening in Houston. Scientists have been trying to develop effective cancer ...
- Scientists discover 'kill switch' that triggers death of cancer cell in breakthroughon November 23, 2023 at 8:02 am
A research team in California have had a breakthrough in possible cancer treatments as they discover a way to cause cell death. Scientists from the University of California, Davis (UCD) have found a ...
via Bing News